Shopping Cart
Remove All
  • TargetMol
    Your shopping cart is currently empty

Malantide acetate(86555-35-3 free base)

Copy Product Info
🥰Excellent
Catalog No. TP1789L

Malantide acetate is a dodecapeptide phosphorylated by cyclic AMP-dependent protein kinase (PKA), and increases PKA activity.Malantide is a synthetic peptide that is phosphorylated by PKA and is used to measure PKA activity in vitro.

Malantide acetate(86555-35-3 free base)

Malantide acetate(86555-35-3 free base)

Copy Product Info
🥰Excellent
Catalog No. TP1789L
Malantide acetate is a dodecapeptide phosphorylated by cyclic AMP-dependent protein kinase (PKA), and increases PKA activity.Malantide is a synthetic peptide that is phosphorylated by PKA and is used to measure PKA activity in vitro.
Pack SizePriceUSA WarehouseGlobal WarehouseQuantity
1 mg$33In StockIn Stock
5 mg$72In StockIn Stock
10 mg$111In StockIn Stock
25 mg$200In StockIn Stock
50 mg$292In StockIn Stock
100 mg$415In StockIn Stock
200 mg$548In StockIn Stock
Add to Cart
Add to Quotation
In Stock Estimated shipping dateUSA Warehouse[1-2 days] Global Warehouse[5-7 days]
All TargetMol products are for research purposes only and cannot be used for human consumption. We do not provide products or services to individuals. Please comply with the intended use and do not use TargetMol products for any other purpose.
Questions
TargetMol
View More

Batch Information

Select Batch
Purity:>99.99%
Contact us for more batch information

Resource Download

Product Introduction

Bioactivity
Description
Malantide acetate is a dodecapeptide phosphorylated by cyclic AMP-dependent protein kinase (PKA), and increases PKA activity.Malantide is a synthetic peptide that is phosphorylated by PKA and is used to measure PKA activity in vitro.
In vitro
Malantide is a dodecapeptide, and increases PKA activity in a variety of tissues[1]. Malantide is phosphorylated by PKA[2].
Chemical Properties
Molecular Weight1693.97
FormulaC74H128N22O23
SmilesO=C([C@H](CCC(O)=O)NC([C@@H](NC([C@H](C(C)C)NC([C@H](CO)NC(CNC([C@H](CO)NC([C@H](CCCNC(N)=N)NC([C@H](CCCCN)NC([C@H]([C@H](O)C)NC([C@@H](N)CCCNC(N)=N)=O)=O)=O)=O)=O)=O)=O)=O)CC1=CC=C(O)C=C1)=O)N(CCC2)[C@@H]2C(N[C@@H](CC(C)C)C(N[C@@H](CCCCN)C(N[C@H](C(O)=O)[C@@H](C)CC)=O)=O)=O.CC(O)=O
Relative Density.no data available
SequenceH-Arg-Thr-Lys-Arg-Ser-Gly-Ser-Val-Tyr-Glu-Pro-Leu-Lys-Ile-OH
Sequence ShortRTKRSGSVYEPLKI
Storage & Solubility Information
Storagekeep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature.
Solubility Information
DMSO: 5 mM, Sonication is recommended.
Solution Preparation Table
DMSO
1mg5mg10mg50mg
1 mM0.5903 mL2.9516 mL5.9033 mL29.5165 mL
5 mM0.1181 mL0.5903 mL1.1807 mL5.9033 mL

Calculator

  • Molarity Calculator
  • Dilution Calculator
  • Reconstitution Calculator
  • Molecular Weight Calculator

In Vivo Formulation Calculator (Clear solution)

Please enter your animal experiment information in the following box and click Calculate to obtain the stock solution preparation method and in vivo formula preparation method:
TargetMol | Animal experiments For example, if the intended dosage is 10 mg/kg for animals weighing 20 g , with a dosing volume of 100 μL per animal, TargetMol | Animal experiments and a total of 10 animals are to be administered, using a formulation of TargetMol | reagent 10% DMSO+ 40% PEG300+ 5% Tween 80+ 45% Saline/PBS/ddH2O , the resulting working solution concentration would be 2 mg/mL.
Stock Solution Preparation:

Dissolve 2 mg of the compound in 100 μL DMSOTargetMol | reagent to obtain a stock solution at a concentration of 20 mg/mL . If the required concentration exceeds the compound's known solubility, please contact us for technical support before proceeding.

Preparation of the In Vivo Formulation:

1) Add 100 μL of the DMSOTargetMol | reagent stock solution to 400 μL PEG300TargetMol | reagent and mix thoroughly until the solution becomes clear.

2) Add 50 μL Tween 80 and mix well until fully clarified.

3) Add 450 μL Saline,PBS or ddH2OTargetMol | reagent and mix thoroughly until a homogeneous solution is obtained.

This example is provided solely to demonstrate the use of the In Vivo Formulation Calculator and does not constitute a recommended formulation for any specific compound. Please select an appropriate dissolution and formulation strategy based on your experimental model and route of administration.
All co-solvents required for this protocol, includingDMSO, PEG300/PEG400, Tween 80, SBE-β-CD, and Corn oil, are available for purchase on the TargetMol website.
1 Enter information below:
mg/kg
g
μL
2 Enter the in vivo formulation:
% DMSO
%
% Tween 80
% Saline/PBS/ddH2O

Dose Conversion

You can also refer to dose conversion for different animals. More Dose Conversion

Tech Support

Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc

Keywords

Related Tags: buy Malantide acetate(86555-35-3 free base) | purchase Malantide acetate(86555-35-3 free base) | Malantide acetate(86555-35-3 free base) cost | order Malantide acetate(86555-35-3 free base) | Malantide acetate(86555-35-3 free base) chemical structure | Malantide acetate(86555-35-3 free base) in vitro | Malantide acetate(86555-35-3 free base) formula | Malantide acetate(86555-35-3 free base) molecular weight